Pharma & Biotech
Tetra Bio-Pharma gearing up for a milestone 2021 as it advances coronavirus drug candidate ARDS-003 to human trials
PreveCeutical turns focus on developing preventive and curative therapies to COVID-19
LexaGene has a disruptive technology that meets critical needs of underserved markets
Only registered members can use this feature.
Copyright © Proactive Investors 2021.
All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC.